Tag: Melvin Vu

Good Doctor to Strengthen Its Position as a Holistic Health Ecosystem in Southeast Asia

This year marks Good Doctor’s third year operation in Indonesia. Since its debut in 2019, Good Doctor is said to record various significant achievements, including 14.2 million users with up to 40 times growth in the country.

In addition, Good Doctor has partnered with more than 45 insurance companies, 500 corporate partners and a major network of third-party administrators (TPA), more than 1,000 hospitals and laboratories, and 2,500 pharmacies throughout Indonesia. The rapid growth of Good Doctor’s network in Indonesia is said to have driven annual business growth up to 864%.

According to the Managing Director of Good Doctor Technology Indonesia, Danu Wicaksana, his team is exploring a Health-as-a-Service partnership, one of the focuses in the pipeline. “We don’t want to offer just a solution, but to create an ecosystem of various stakeholders including the government, laboratories, and clinics,” he told DailySocial.

Good Doctor Technology (GDT) is a joint venture of Ping An Healthcare and Technology (formerly Ping An Good Doctor), Grab, and SoftBank. Initially, Good Doctor was present in Indonesia as a feature called GrabHealth which was embedded into the Grab application in 2019. Then, this service officially became a separate platform in March 2021. Currently, Good Doctor is present in Indonesia and Thailand with regional operations based in Singapore.

In an exclusive interview with DailySocial, Regional CEO of Good Doctor Technology, Melvin Vu said that the platform is currently preparing to become a telehealth provider with a holistic ecosystem in Southeast Asia. The momentum of digital acceleration is fully utilized to develop various health services, therefore, they can accommodate a wider network.

What are Good Doctor’s next steps and strategies?

B2B and Health as a Service

Based on Dukcapil data as of the end of 2021, the number of health workers (nakes) in Indonesia was recorded at 567,910 people, or 0.21% of the total population of 273.87 million people. Meanwhile, health spending through digital platforms in Indonesia is predicted to be $973 million (around Rp. 14.4 trillion) in 2023.

With the uneven distribution of doctors, Melvin believes that telehealth can overcome challenges for a market like Indonesia with large population and geographical condition. He also believes that telehealth can balance the health ecosystem in Indonesia.

In order to stay at the forefront of the telehealth sector, Good Doctor has two main strategies. First, to reach more people by expanding services to the B2B segment. Second, offering Health-as-a-Service (HaaS) solutions by leveraging the strong support for technology, ecosystem, and partners of Good Doctor.

Technology leverage and localization

In the healthcare industry, including virtual health, technology allows wider exploration. Melvin said that Good Doctor has a strong position to execute it due to the technology and experience built by the parent company over the last seven years. For example, the implementation of AI to help doctors in Indonesia understand symptoms, provide diagnoses, and issue drug prescriptions for their patients.

In addition, Melvin said Good Doctor has another added value as it has an in-house doctor whose expertise can be used to carry out quality control services. One of them is developing clinical pathways. For your information, a clinical pathway is a guideline used to carry out evidence-based clinical actions in health care facilities. Every disease has different guidelines.

In general, health service demand is almost the same in all countries in the Southeast Asian region. In this case, Good Doctor developed a solution from Thailand, then customized it for the Indonesian market.

“We are fortunate that Ping An has been in this field for a long time, therefore, we can leverage its proven technology in China. Being a regional player allows us to understand healthcare issues in different markets, learning from each other. With our technology, everything is conceived on how we deliver healthcare virtually,” he said.

However, Melvin also highlighted the essence of being integrated with various stakeholders. Collaborations will enable Good Doctor to deliver a variety of services and create a holistic health ecosystem in the future, whether through hospitals, clinics, companies, or digital platforms.

“Leveraging technology is one thing, it is also important that we customize to localize. We can have different points of view with service integration. Furthermore, this allows us to minimize fault for every integration, every platform is different. Therefore, we can integrate fast. We can deliver a better customer journey to our clients,” he said.

Transition to endemic

Responding to Good Doctor’s move in welcoming endemic, Melvin said that telemedicine or other virtual health services will continue to play a significant role. He said, services for sick care will always be available, but preventive care is no less important.

“We want [Good Doctor] to transcend sick care services to preventive care in order to keep people healthy. We also want to help control and treat chronic diseases. Related products and services that will be developed, also allow them to be connected to IoT devices. Good Doctor has We are in a strong position to do this because we have the technology and understand how to deliver products,” he said.

Furthermore, Melvin ensures that his team will explore new expansions while focusing on working on existing markets in Singapore, Thailand, and Indonesia.

–
Original article is in Indonesian, translated by Kristin Siagian

Good Doctor Perkuat Posisi Sebagai Penyedia Ekosistem Kesehatan Holistik di Asia Tenggara

Tahun ini menandai tiga tahun Good Doctor melayani masyarakat Indonesia. Sejak beroperasi di 2019, Good Doctor menyebut telah mencatatkan berbagai pencapaian signifikan, yakni 14,2 juta pengguna dengan pertumbuhan hingga 40 kali lipat di Indonesia.

Selain itu, Good Doctor telah bermitra dengan lebih dari 45 perusahaan asuransi, 500 mitra korporasi dan jaringan administrator pihak ketiga (TPA) utama, lebih dari 1.000 rumah sakit dan laboratorium, serta 2.500 apotek di seluruh Indonesia. Pesatnya jaringan kemitraan Good Doctor di Indonesia disebut telah mendorong pertumbuhan bisnis secara tahunan hingga 864%.

Menurut Managing Director Good Doctor Technology Indonesia Danu Wicaksana, pihaknya juga sedang menjajaki kemitraan Health-as-a-Service, yakni salah satu agenda yang tengah mereka siapkan. “Kami tidak hanya ingin menawarkan solusi saja, tapi menciptakan ekosistem dari berbagai stakeholder, baik itu pemerintah, laboratorium, dan klinik,” ujarnya kepada DailySocial.

Good Doctor Technology (GDT) merupakan perusahaan patungan antara Ping An Healthcare and Technology (sebelumnya bernama Ping An Good Doctor), Grab, dan SoftBank. Awalnya, Good Doctor hadir di Indonesia sebagai fitur bernama GrabHealth yang di-embed ke dalam aplikasi Grab pada 2019. Kemudian, layanan ini resmi menjadi aplikasi terpisah pada Maret 2021. Saat ini, Good Doctor telah hadir di Indonesia dan Thailand dengan operasi regional berbasis di Singapura.

Dalam sesi wawancara eksklusif dengan DailySocial, Regional CEO Good Doctor Technology Melvin Vu menyebutkan tengah mempersiapkan diri untuk menjadi penyedia telehealth dengan ekosistem holistik di Asia Tenggara. Momentum akselerasi digital dimanfaatkan penuh untuk mengembangkan berbagai layanan kesehatan sehingga dapat mengakomodasi kebutuhan lebih luas.

Bagaimana langkah dan strategi Good Doctor selanjutnya?

B2B dan Health-as-a-Service

Berdasarkan data Dukcapil per akhir 2021, jumlah tenaga kesehatan (nakes) di Indonesia tercatat sebanyak 567.910 orang atau 0,21% dari total penduduk yang mencapai 273,87 juta jiwa. Sementara, pengeluaran kesehatan melalui platform digital di Indonesia diprediksi sebesar $973 juta (sekitar Rp14,4 triliun) di 2023.

Dengan sebaran dokter yang tidak merata, Melvin menilai telehealth dapat mengatasi tantangan bagi pasar seperti Indonesia yang memiliki populasi dan kondisi geografis luas. Ia juga meyakini telehealth dapat menyeimbangkan ekosistem kesehatan di Indonesia.

Agar tetap terdepan di sektor telehealth, Good Doctor memiliki dua strategi utama. Pertama, menjangkau lebih banyak orang dengan memperluas layanan ke segmen B2B. Kedua, menawarkan solusi Health-as-a-Service (HaaS) dengan memanfaatkan dukungan kuat pada teknologi, ekosistem, hingga mitra yang dimiliki Good Doctor.

Leverage teknologi dan lokalisasi

Di industri kesehatan, termasuk virtual health, ada banyak yang dapat dieskplorasi dengan teknologi. Melvin menilai Good Doctor punya posisi kuat untuk mengeksekusinya berkat teknologi dan pengalaman yang dibangun oleh induk usaha selama tujuh tahun terakhir. Misalnya, implementasi AI untuk membantu para dokter di Indonesia memahami gejala, memberi diagnosis, dan membuat resep obat bagi pasiennya.

Selain itu, ungkap Melvin, Good Doctor juga memiliki nilai tambah lain karena memiliki dokter in-house yang ekspertisnya dapat dimanfaatkan untuk melakukan quality control layanan. Salah satunya adalah mengembangkan clinical pathway. Sekadar informasi, clinical pathway merupakan sebuah pedoman yang digunakan untuk melakukan tindakan klinis berbasis bukti pada fasilitas layanan kesehatan. Setiap penyakit punya pedoman berbeda.

Umumnya, kebutuhan layanan kesehatan hampir sama di semua negara di kawasan Asia Tenggara. Dalam kasus ini, Good Doctor membawa solusi yang ada di Thailand, kemudian dikustomisasi untuk pasar Indonesia.

“Kami beruntung Ping An telah lama di bidang ini sehingga kami dapat leverage teknologinya yang sudah terbukti di Tiongkok. Menjadi pemain regional juga membuat kami dapat memahami isu healthcare di pasar berbeda, learning each other. Dengan teknologi kami, everything is conceived on how we deliver healthcare virtually,” tuturnya.

Kendati demikian, Melvin juga menyoroti pentingnya untuk terintegrasi dengan berbagai stakeholder. Kolaborasi akan memampukan Good Doctor untuk menghadirkan berbagai layanan dan menciptakan ekosistem kesehatan holistik di masa depan, baik melalui rumah sakit, klinik, perusahaan, maupun platform digital.

“Leveraging technology is one thing, but it is important that we customize to localize. Kami dapat memiliki berbagai sudut pandang ketika melakukan integrasi layanan. Dan ini memungkinkan kami untuk membuat kesalahan minim karena setiap integrasi, setiap platform itu berbeda. Jadi kami bisa integrasi dengan cepat. We can deliver a better customer journey to our clients,” jelasnya.

Transisi ke endemi

Menjawab langkah Good Doctor menyambut endemi, Melvin menilai telemedicine atau layanan kesehatan virtual lainnya akan tetap memainkan peran signifikan. Menurutnya, layanan bagi perawatan sakit (sick care) akan selalu ada, tetapi layanan pencegahan (preventive care) juga tak kalah penting.

“Kami ingin [Good Doctor] transcend layanan sick care ke preventive care agar menjaga orang tetap sehat. Kami juga ingin membantu mengontrol dan menangani penyakit kronis. Produk dan layanan terkait yang akan dikembangkan, juga memungkinkan agar dapat terhubung ke perangkat IoT. Good Doctor punya posisi kuat untuk melakukannya karena kami punya teknologi dan memahami cara deliver produk,” ujarnya.

Langkah selanjutnya, Melvin memastikan bahwa pihaknya akan menjajaki ekspansi baru sambil fokus menggarap pasar existing di Singapura, Thailand, dan Indonesia.